Using artificial intelligence to improve treatment for multiple brain metastases
Official title: An artificial intelligence-driven distributed stereotactic radiosurgery strategy for multiple brain metastases management
Funded at Ut Southwestern Medical Center · NIH-10749026 · Data updated 2026-11-12
This study is testing a new AI tool to help doctors plan better treatments for patients with multiple brain tumors, aiming to make radiation therapy more effective while keeping side effects low and improving quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | January 1, 2019 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $526,311 |
| NIH project number | 5R01CA235723-06 |
| Project ID | NIH-10749026 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with multiple brain metastases who are seeking advanced treatment options.
✕Less likely to help
Patients with a single brain metastasis or those who are not candidates for stereotactic radiosurgery may not benefit from this research.
What this research studies
This research focuses on enhancing the treatment of multiple brain metastases (mBMs) using an artificial intelligence-driven approach. It aims to develop a treatment planning system that utilizes AI to optimize stereotactic radiosurgery (SRS), a method that delivers precise radiation to tumors while minimizing damage to surrounding healthy tissue. The study will involve clinical trials to evaluate the effectiveness of this AI system in improving treatment outcomes and preserving patients' quality of life post-treatment. By addressing the challenges of treating multiple brain tumors, this research seeks to provide a safer and more effective treatment option for patients.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and quality of life for patients with multiple brain metastases.
How similar studies have gone: Other research has shown promise in using AI for treatment planning in various medical fields, indicating potential success for this novel approach in managing multiple brain metastases.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Gu, Xuejun — Ut Southwestern Medical Center
- Study coordinator: Gu, Xuejun
Related research
Other NIH-funded projects on the same topics.
-
Understanding and interrupting brain metastasis in cancer patients
A national research effort at Stanford aims to understand why cancer spreads to the brain and to develop ways to interrupt it, with the goal of improving survival and quality of life for people with cancer.
-
Rational approaches to improve treatment for breast cancer that has spread to the brain
Aimed at boosting how well a HER2-targeted antibody-drug conjugate works for people whose breast cancer has spread to the brain.
-
Understanding how brain metastasis in triple-negative breast cancer is shaped by tumor-immune interactions
A patient-focused program aims to learn why TNBC spreads to the brain and how the immune system interacts with those cancer cells, with a focus on women of African ancestry.
-
AI-driven automatic treatment planning for brain metastases radiotherapy
A new AI-based system helps plan precise stereotactic radiosurgery for people with multiple brain metastases.
-
Endocrine therapy and radiation work together to reduce brain metastases
Aims to understand how hormone therapy and radiation together help the body fight breast cancer that has spread to the brain, especially in younger women.
-
Personalized brain metastases risk map to guide radiotherapy
A new approach uses personal MRI data to predict where brain metastases might develop so radiation can target high-risk areas and spare healthy brain tissue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.